Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism SGMS2 inhibitors(sphingomyelin synthase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | - | 17 Jan 2025 | |
Atherosclerosis | Discovery | - | 17 Jan 2025 | |
Digestive System Disorders | Discovery | - | 17 Jan 2025 | |
Endocrinology and Metabolic Disease | Discovery | - | 17 Jan 2025 | |
Neoplasms | Discovery | - | 17 Jan 2025 | |
Respiratory Diseases | Discovery | - | 17 Jan 2025 | |
Xerophthalmia | Discovery | - | 17 Jan 2025 |